SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-300042
Filing Date
2021-10-15
Accepted
2021-10-15 16:16:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d230796df3.htm F-3 357018
2 EX-5.1 d230796dex51.htm EX-5.1 34817
3 EX-23.1 d230796dex231.htm EX-23.1 1902
4 GRAPHIC g230796dsp001.jpg GRAPHIC 1430
5 GRAPHIC g230796dsp001a.jpg GRAPHIC 1954
6 GRAPHIC g230796dsp3.jpg GRAPHIC 6085
7 GRAPHIC g230796dsp45.jpg GRAPHIC 6105
  Complete submission text file 0001193125-21-300042.txt   416701
Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Filer) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-260283 | Film No.: 211326255
SIC: 2834 Pharmaceutical Preparations